Cargando…
N-Acetylaspartate Biomarker of Stroke Recovery: A Case Series Study
BACKGROUND AND PURPOSE: Strong experimental neurobehavioral evidence suggests that intensive training improves arm motor disability after stroke. Yet, we still have only limited understanding why some patients recover more completely and others do not. This is in part due to our limited knowledge of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294783/ https://www.ncbi.nlm.nih.gov/pubmed/34296219 |
_version_ | 1783725302700048384 |
---|---|
author | Austin, Tyler Bani-Ahmed, Ali Cirstea, Mihaela Carmen |
author_facet | Austin, Tyler Bani-Ahmed, Ali Cirstea, Mihaela Carmen |
author_sort | Austin, Tyler |
collection | PubMed |
description | BACKGROUND AND PURPOSE: Strong experimental neurobehavioral evidence suggests that intensive training improves arm motor disability after stroke. Yet, we still have only limited understanding why some patients recover more completely and others do not. This is in part due to our limited knowledge of the neurobiological principles of recovery from stroke. Mounting evidence suggests that functional and structural remapping of the primary motor cortex (M1) plays a major role in arm recovery after stroke. We used MR Spectroscopy to test the hypothesis that therapy-related arm improvement is associated with changes in levels of a putative marker of neuronal integrity (N-acetylaspartate, NAA) in M1 controlling the paretic arm (ipsilesional M1) in chronic stroke patients (n=5). METHODS: Patients (1 female, age, mean ± SD, 58.4 ± 5.8 years) underwent 4-week arm-focused motor training (1080 repetitions of a reach-to-grasp task) at 13.6 ± 5.3 months after stroke onset. NAA levels in the ipsilesional M1 and arm impairment (Fugl-Meyer, FM, 66=normal; proximal FM, FM(p), 30=normal) were assessed prior to and immediately after training. RESULTS: At baseline, patients exhibited moderate-to-mild arm impairment (FM, 47.2 ± 18.8, FM(p), 22.2 ± 8.6) and showed lower levels of NAA compared with age/sex-matched healthy controls (10.2 ± 0.9 mM in patients vs. 11.6 ± 1.6 mM in controls, p=0.03). After training, arm impairment improved (FM by 7%, 50.6 ± 17.5, p=0.01; FMp, by 5%, 23.4 ± 8.2, p=0.2) and NAA levels increased by 10.5% (11.2 ± 1.2 mM, p=0.1). Changes in NAA positively correlated with changes in FM (r=0.63, p=0.2) and FM(p) (r=0.93, p=0.03), suggesting that patients who show greater neuronal changes have a better chance of recovery. CONCLUSIONS: Our data suggest the potential use of M1 NAA as a biomarker of motor recovery after stroke. However, because of our small sample, these preliminary results should be interpreted cautiously. Further work with larger sample sizes is warranted. |
format | Online Article Text |
id | pubmed-8294783 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
record_format | MEDLINE/PubMed |
spelling | pubmed-82947832021-07-21 N-Acetylaspartate Biomarker of Stroke Recovery: A Case Series Study Austin, Tyler Bani-Ahmed, Ali Cirstea, Mihaela Carmen Front Neurol Neurosci Res Article BACKGROUND AND PURPOSE: Strong experimental neurobehavioral evidence suggests that intensive training improves arm motor disability after stroke. Yet, we still have only limited understanding why some patients recover more completely and others do not. This is in part due to our limited knowledge of the neurobiological principles of recovery from stroke. Mounting evidence suggests that functional and structural remapping of the primary motor cortex (M1) plays a major role in arm recovery after stroke. We used MR Spectroscopy to test the hypothesis that therapy-related arm improvement is associated with changes in levels of a putative marker of neuronal integrity (N-acetylaspartate, NAA) in M1 controlling the paretic arm (ipsilesional M1) in chronic stroke patients (n=5). METHODS: Patients (1 female, age, mean ± SD, 58.4 ± 5.8 years) underwent 4-week arm-focused motor training (1080 repetitions of a reach-to-grasp task) at 13.6 ± 5.3 months after stroke onset. NAA levels in the ipsilesional M1 and arm impairment (Fugl-Meyer, FM, 66=normal; proximal FM, FM(p), 30=normal) were assessed prior to and immediately after training. RESULTS: At baseline, patients exhibited moderate-to-mild arm impairment (FM, 47.2 ± 18.8, FM(p), 22.2 ± 8.6) and showed lower levels of NAA compared with age/sex-matched healthy controls (10.2 ± 0.9 mM in patients vs. 11.6 ± 1.6 mM in controls, p=0.03). After training, arm impairment improved (FM by 7%, 50.6 ± 17.5, p=0.01; FMp, by 5%, 23.4 ± 8.2, p=0.2) and NAA levels increased by 10.5% (11.2 ± 1.2 mM, p=0.1). Changes in NAA positively correlated with changes in FM (r=0.63, p=0.2) and FM(p) (r=0.93, p=0.03), suggesting that patients who show greater neuronal changes have a better chance of recovery. CONCLUSIONS: Our data suggest the potential use of M1 NAA as a biomarker of motor recovery after stroke. However, because of our small sample, these preliminary results should be interpreted cautiously. Further work with larger sample sizes is warranted. 2021 2021-03-31 /pmc/articles/PMC8294783/ /pubmed/34296219 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Article Austin, Tyler Bani-Ahmed, Ali Cirstea, Mihaela Carmen N-Acetylaspartate Biomarker of Stroke Recovery: A Case Series Study |
title | N-Acetylaspartate Biomarker of Stroke Recovery: A Case Series Study |
title_full | N-Acetylaspartate Biomarker of Stroke Recovery: A Case Series Study |
title_fullStr | N-Acetylaspartate Biomarker of Stroke Recovery: A Case Series Study |
title_full_unstemmed | N-Acetylaspartate Biomarker of Stroke Recovery: A Case Series Study |
title_short | N-Acetylaspartate Biomarker of Stroke Recovery: A Case Series Study |
title_sort | n-acetylaspartate biomarker of stroke recovery: a case series study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294783/ https://www.ncbi.nlm.nih.gov/pubmed/34296219 |
work_keys_str_mv | AT austintyler nacetylaspartatebiomarkerofstrokerecoveryacaseseriesstudy AT baniahmedali nacetylaspartatebiomarkerofstrokerecoveryacaseseriesstudy AT cirsteamihaelacarmen nacetylaspartatebiomarkerofstrokerecoveryacaseseriesstudy |